3rd Annual Biomarkers Conference
An essential addition from discovery to approval in clinical developmentMar 23,2010 - Mar 24,2010
BSG House, London, England, United Kingdom
-
Highlights
This conference will enable you to identify and overcome challenges on how to incorporate biomarkers into your discovery programs as well as highlighting new technologies and strategies to improved prevention and care approaches.
Key Speakers
• Mike Lau, Principal Clinical Development Scientist, GSK Oncology
• James Weatherall, Global Lead, Biomedical Informatics, AstraZeneca
• David W. Moskowitz, Chairman, CEO & Chief Medical Officer, GenoMed
• Fabio Magrini, Director, Inflammation and Autoimmunity, MedImmune
• Hassan Rahmoune, Head of Translational Medicine & Discovery Biomarkers, University of Cambridge/Psynova
• Patrick Sluss, Director, Special Chemistry Core Laboratories, Massachusetts General Hospital, Associate Professor, Harvard Medical School
• Christian Rohlff, CEO, Oxford BioTherapeutics
• Richard Kennedy, Vice President of Translational Research and Development, Almac group
• Stéphane Lucchini, Business Manager, Biovays
• Patricia Hurley,Head of Project Management & Head of Biomarkers Division, ERA Consulting UK
• Peter Duncan, Director of Business Development, Clinical Diagnostics, Definiens
• Huw Davies, Director Business Development, Pronota
• Eddie Blair, Director, Integrated Medicines
• Niro Ramachandran, R&D Manager, Life Technologies
Event Reminder
- Registration Open
- Call for Papers
- Call for Speakers
- Receive GTM eblast updates
- Security Code:
Event Profile
- Theme: An essential addition from discovery to approval in clinical development
Contact Details
- Contact person: Sara Peerun
- Event website: http://www.visiongain.com/Conference.aspx?cid=258
- Phone: +44 02073366100
- Fax:
Tags
Contact Organizer
